Biopharma HR leaders share how they are taking a fresh look at developing and engaging their leaders as we emerge from the pandemic.

Africa is ripe for increasing biomedical research and development; however, many African diaspora scientists have gone abroad for other opportunities. Many who do want to return face several major barriers in increasing their research links to the continent. To better understand these impediments, Egon Zehnder partnered with the UK Medical Research Council (MRC) to interview 15 African biomedical scientists from around the world to explore what is preventing African biomedical scientists based abroad from increasing their involvement with African research institutes and local African scientific talent and potential solutions to overcome these barriers.

Evolving personal work patterns are demonstrating people’s amazing adaptability in the face of the pandemic.

Evolving personal work patterns are demonstrating people’s amazing adaptability in the face of the pandemic: people are becoming much more comfortable and efficient at using virtual meetings, European Biotech leaders reveal to Egon Zehnder in a recent digital gathering.

On June 30, Egon Zehnder virtually gathered 15 top HR leaders from across biopharma, including European-based and U.S.-based companies, ranging from big pharma to start-up biotech. It was a lively discussion, with participants curious to learn from one another and generous in sharing their own insights, hopes, and concerns.

Highlights from the fourth round of digital gatherings with European Biotech CEOs, hosted by Egon Zehnder.

Highlights from the second round of digital gatherings with European Biotech CEOs, hosted by Egon Zehnder.

Senior Biotech R&D execs brainstorm on saving clinical trials, modifying procedures, and getting people back to work.

Egon Zehnder's lessons from how the biopharma industry has responded to Covid-19 with focus, collaboration and resilience.

Healthcare CEOs in Asia have embraced that duality and in a teleconference organized by Egon Zehnder, they gathered to discuss the fallout from COVID-19.